EVAX logo

EVAXEvaxion Biotech

$3.94
$0.30
(8.24%)
Pre-Market
Updated: 08:46 AM EDT·Prev Close $3.64
Mkt Cap$30.36M
Vol112.00
News
all
press releases
News Placeholder
Evaxion Appoints Helen Tayton-Martin As Chief Executive
Stocktwits
News Placeholder
Natural Killer Cell Therapies Lead $254B Immunotherapy Market Transformation
Natural Killer Cell Therapies Lead $254B Immunotherapy Market Transformation Natural Killer Cell Therapies Lead $254B Immunotherapy Market Transformation PR Newswire VANCOUVER, BC, Oct. 17, 2025...
PR Newswire
News Placeholder
Evaxion Stock Jumps A Whopping 43% Pre-Market – Here’s What Happened
The company said it will receive a cash payment of $7.5 million, in addition to future milestone payments of up to $592 million.
Stocktwits
<
...
1
>

Advertisement|Remove ads.